Acoustically induced blood stasis and in vivo optical spectroscopy

• US 8,855,738 B2
• Filed: 08/17/2006
• Issued: 10/07/2014
• Est. Priority Date: 08/18/2005
• Status: Active Grant

• Current Assignee: University of Rochester
• Original Assignee: University of Rochester
• Inventors: Yu, Yan, Winey, Brian, Liao, Lydia
• Primary Examiner(s): Le, Long V.
• Assistant Examiner(s): PENG, BO JOSEPH
• Application Number:
  US11/505,492
• Publication Number:
  US 20070055126A1
• Time in Patent Office: 2,973 Days
• Field of Search: 600/407, 600/473, 600/476
• US Class Current: 600/407
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation
• CPC Class Codes: A61B 5/4381 Prostate evaluation or disorder diagnosis
• CPC Class Codes: A61B 8/0825 for diagnosis of the breast, e.g. mammography
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

Ultrasound-induced blood stasis has been observed for more than thirty years. Most of the literature has been focused on the health risks associated with this phenomenon and methods employed to prevent stasis from occurring during ultrasound imaging. To date, experimental observations have been either in vitro or invasive. The current work demonstrates ultrasound-induced blood stasis in murine tumor and nontumor tissue, observed through noninvasive measurements of optical spectroscopy, and discusses possible diagnostic uses for this previously undesirable effect of ultrasound.

Claims

1. A method for diagnosis of a region of interest in a patient, the method comprising:

(a) causing an oxy/deoxyhemoglobin shift in the region of interest using an ultrasound signal;

(b) performing optical spectroscopy on the region of interest to obtain a ratio of optical absorption values at different wavelengths, a change of the ratio over time representing the oxy/deoxyhemoglobin shift; and

(c) determining whether the region of interest contains tumor tissue by determining whether the ratio obtained in step (b) correlates with the ultrasound signal used in step (a), wherein a correlation between the ratio and the ultrasound signal is higher in a non-tumor case than in a tumor case.

2. The method of claim 1, wherein the region of interest is in a breast of the patient.

3. The method of claim 2, wherein step (b) is performed with an instrument while the instrument is held stationary relative to the region of interest.

4. The method of claim 3, wherein the instrument comprises an ultrasound transducer and an ultrasound probe, and wherein the ultrasound transducer and the ultrasound probe are moved within the instrument while the instrument is held stationary relative to the region of interest and while step (b) is performed.

5. The method of claim 1, wherein the region of interest is in a prostate of the patient.

6. The method of claim 5, wherein:

step (a) is performed with an ultrasound probe; and

step (b) is performed with an optical fiber probe inserted into a urethra of the patient.

7. The method of claim 6, wherein the ultrasound probe is inserted into a rectum of the patient.

8. The method of claim 6, wherein the ultrasound probe is applied to an abdominal wall of the patient.

9. The method of claim 1, wherein step (a) is performed using a stationary ultrasound wave.

10. The method of claim 1, wherein step (a) is performed using a stationary ultrasound wave.

11. The method of claim 1, wherein the different wavelengths are 560 nm and 540 nm.

12. A system for diagnosis of a region of interest in a patient, the system comprising:

(a) an ultrasound device configured to cause an oxy/deoxyhemoglobin shift in the region of interest using an ultrasound signal; and

(b) a diagnostic device configured to perform optical spectroscopy on the region of interest to obtain a ratio of optical absorption values at different wavelengths, a change of the ratio over time representing the oxy/deoxyhemoglobin shift, and configured to determine whether the region of interest contains tumor tissue by determining whether the ratio correlates with the ultrasound signal, wherein the diagnostic device is configured to take into account that a correlation between the ratio and the ultrasound signal is higher in a non-tumor case than in a tumor case; and

(c) wherein the diagnostic device includes a computer display comprising a display area for tumor correlation and a display area for non-tumor correlation, said display device displaying at least one of the correlations for non-tumor tissue and for tumor tissue as a correlation metric indicative of the presence of tumor or non-tumor tissue at the region of interest.

13. The system of claim 12, further comprising a holding member configured to hold the system stationary relative to the region of interest.

14. The system of claim 13, wherein the ultrasound device comprises an ultrasound transducer and an ultrasound probe, and wherein the ultrasound transducer and the ultrasound probe are movable within the ultrasound device while the system is held stationary relative to the region of interest.

15. The system of claim 12, wherein the diagnostic device comprises an optical her probe for insertion into a urethra of the patient.

16. The system of claim 15, wherein the ultrasound device is configured to be inserted into a rectum of the patient.

17. The system of claim 15, wherein the ultrasound device is configured to be applied to an abdominal wall of the patient.

18. The system of claim 12, wherein the ultrasound device causes the blood stasis oxy/deoxyhemoglobin shift in the region of interest using a stationary ultrasound wave.

19. The system of claim 12, wherein the different wavelengths are 560 nm and 540 nm.